The Cardioprotective Effect Of Human Glucagon‐Like Peptide1 Receptor Agonist (Semaglutide) on Cisplatin‐Induced Cardiotoxicity in Rats: Targeting Mitochondrial Functions, Dynamics, Biogenesis, And Redox Status Pathways

(2023). The Cardioprotective Effect Of Human Glucagon‐Like Peptide1 Receptor Agonist (Semaglutide) on Cisplatin‐Induced Cardiotoxicity in Rats: Targeting Mitochondrial Functions, Dynamics, Biogenesis, And Redox Status Pathways. Egyptian Society of Diabetes and Lipidology Journal, 3(2), -. doi: 10.21608/esdlj.2023.456215

. "The Cardioprotective Effect Of Human Glucagon‐Like Peptide1 Receptor Agonist (Semaglutide) on Cisplatin‐Induced Cardiotoxicity in Rats: Targeting Mitochondrial Functions, Dynamics, Biogenesis, And Redox Status Pathways", Egyptian Society of Diabetes and Lipidology Journal, 3, 2, 2023, -. doi: 10.21608/esdlj.2023.456215

(2023). 'The Cardioprotective Effect Of Human Glucagon‐Like Peptide1 Receptor Agonist (Semaglutide) on Cisplatin‐Induced Cardiotoxicity in Rats: Targeting Mitochondrial Functions, Dynamics, Biogenesis, And Redox Status Pathways', Egyptian Society of Diabetes and Lipidology Journal, 3(2), pp. -. doi: 10.21608/esdlj.2023.456215

The Cardioprotective Effect Of Human Glucagon‐Like Peptide1 Receptor Agonist (Semaglutide) on Cisplatin‐Induced Cardiotoxicity in Rats: Targeting Mitochondrial Functions, Dynamics, Biogenesis, And Redox Status Pathways. Egyptian Society of Diabetes and Lipidology Journal, 2023; 3(2): -. doi: 10.21608/esdlj.2023.456215